EX-5.1 2 tm2123745d2_ex5-1.htm EXHIBIT 5.1

Exhibit 5.1

 

Consent of Independent Registered Public Accounting Firm

 

Cardiol Therapeutics Inc.

Oakville, Ontario

 

We hereby consent to the use in the Prospectus constituting a part of this Registration Statement of our report dated March 31, 2021, relating to the financial statements of Cardiol Therapeutics Inc., which is contained in that Prospectus.

 

/s/ BDO Canada LLP

 

BDO Canada LLP

Montréal, Québec

 

August 3, 2021